deltatrials

Centre Leon Berard Clinical Trials

Sponsors / Centre Leon Berard

ClinicalTrials.gov lists 183 trials for which Centre Leon Berard is named as lead sponsor. The portfolio currently includes 33 recruiting studies, 9 active non-recruiting studies, and 82 completed studies. 19 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Cumulative planned enrollment across all listed trials is 50,833 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

183
Total Trials
33
Recruiting
9
Other Active
82
Completed
19
Terminated / Withdrawn
50,833
Total Enrollment

Termination reasons: Recruitment68% · Other26% · Efficacy5%

Recent Terminations

  • NCT06150040 Phase PHASE1/PHASE2 Stopped Feb 2025
    Acute Myeloid Leukemia Refractory
    "low recruitment rate"
  • NCT05442749 Phase PHASE2 Stopped Aug 2024
    Metastatic Pancreatic Cancer
    "Study not feasible, patient accrual rate too low."
  • NCT04244955 Stopped Sep 2021
    Pediatric Cancer
    "Investigator's decision"
  • NCT04094077 Phase PHASE2 Stopped Feb 2021
    Brain Metastases
    "Study stopped after a negative result delivred by the CPP for a substancial modification of the protocol"
  • NCT02700308 Phase PHASE2 Stopped Dec 2020
    Solid Tumors
    "DECISION OF THE SPONSOR AND THE COORDINATING INVESTIGATOR DUE TO RECRUITMENT DIFFICULTIES AND CHANGES IN INTERVENTIONAL RADIOLOGY PRACTICES"
  • NCT03441139 Phase NA Stopped Aug 2020
    Musculoskeletal Pain
    "Difficulty to recruit patient."
  • NCT03276819 Phase NA Stopped Jul 2020
    Head and Neck Squamous Cell Carcinoma (HNSCC)
    "Early termination of the study, since July 31, 2020 for insufficient recruitment"
  • NCT03408652 Phase PHASE3 Stopped Jun 2020
    Metastatic Renal Cell Carcinoma
    "lack of recruitment"
  • NCT02797405 Phase NA Stopped Mar 2020
    Esophagus Cancer
    "Withdrawal of analysis study Partner."
  • NCT02728167 Phase NA Stopped Aug 2018
    Liver Metastasis
    "Poor accrual"

Active Trials (9 total)

Top Conditions

Breast cancer (11) Cancer (9) Colorectal cancer (8) Advanced cancer (4) Metastatic breast cancer (4) Metastatic renal cell carcinoma (4) Neoplasms (4) Advanced solid tumor (2) Anesthesia (2) Cancer of head and neck (2)

Top Locations

Lyon, France (170) Paris, France (59) Bordeaux, France (56) Villejuif, France (49) Marseille, France (48) Lille, France (47) Toulouse, France (41) Nice, France (37) Montpellier, France (34) Saint-Herblain, France (34)